Francis Anokye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francis Anokye has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Amy Hurford
Department of Mathematics and Statistics, Memorial University of Newfoundland, Elizabeth Ave, St. John’s, A1B 3X9, NL, Canada
3 shared publicationsMichael Wz Li
Science Policy Integration Branch, Public Health Agency of Canada, Guelph, Ontario, Canada
2 shared publicationsSteve Walker
Affiliation Department of Mathematics and Statistics, McMaster University, Hamilton, Ontario, Canada
2 shared publications- Amy Hurford
Department of Biology, Memorial University of Newfoundland, St. John’s, Canada
1 shared publication Bilal Saleh Husain
University of New Brunswick, Department of Mathematics and Statistics, Fredericton, NB E3B 5A3, Canada
1 shared publication- Brian Gaas
Government of Yukon, Department of Health and Social Services, Whitehorse, YT Y1A 3T8, Canada
1 shared publication
Latest Publications
- Open Access
High vaccine coverage and non-pharmaceutical interventions decreased hospitalizations and deaths due to the Omicron variant in Newfoundland and Labrador, Canada
The Canadian province of Newfoundland and Labrador (NL) had high vaccination coverage, and few infections were reported prior to the establishment of the Omicron variant. We investigated whether changes in the timing and rate of booster dose administration could have reduced severe disease outcome and reliance on non-pharmaceutical interventions (NPIs) during the Omicron wave in NL. We used a vaccination-stratified epidemiological model calibrated to serology data to investigate the impact of vaccination relative to counterfactual vaccination strategies under actual, strict and no NPI scenarios. Compared with a Canadian vaccination rate scenario, the actual vaccination rollout in NL was estimated to have prevented approximately 519 hospitalizations and 122 deaths from December 15, 2021 to December 15, 2022, corresponding to reductions of 25.9% and 30.9%, respectively. These reductions reflected contributions from NL’s higher initial primary series coverage (81.3%), higher final booster dose coverage (57.3%), and the implementation of various NPIs for 89 days after the Omicron BA.1 variant became established. Earlier and faster administration of booster doses reduced the duration of strict NPIs required to achieve hospitalization targets. Our findings show how the timing and rate of vaccination rollout can complement NPIs to reduce severe disease and the duration for which strict NPIs are required.
Open AccessHigh vaccine coverage and non-pharmaceutical interventions decreased hospitalizations and deaths due to the Omicron variant in Newfoundland and Labrador, Canada
The Canadian province of Newfoundland and Labrador (NL) had high vaccination coverage, and few infections were reported prior to the establishment of the Omicron variant. We investigated whether changes in the timing and rate of booster dose administration could have reduced severe disease outcome and reliance on non-pharmaceutical interventions (NPIs) during the Omicron wave in NL. We used a vaccination-stratified epidemiological model calibrated to serology data to investigate the impact of vaccination relative to counterfactual vaccination strategies under actual, strict and no NPI scenarios. Compared with a Canadian vaccination rate scenario, the actual vaccination rollout in NL was estimated to have prevented approximately 519 hospitalizations and 122 deaths from December 15, 2021 to December 15, 2022, corresponding to reductions of 25.9% and 30.9%, respectively. These reductions reflected contributions from NL’s higher initial primary series coverage (81.3%), higher final booster dose coverage (57.3%), and the implementation of various NPIs for 89 days after the Omicron BA.1 variant became established. Earlier and faster administration of booster doses reduced the duration of strict NPIs required to achieve hospitalization targets. Our findings show how the timing and rate of vaccination rollout can complement NPIs to reduce severe disease and the duration for which strict NPIs are required.
- Open Access
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (4) , e1013562
Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada
The highly transmissible Omicron variant of SARS-CoV-2 caused many infections in Newfoundland and Labrador, Canada, and the fraction of infections that were unreported varied as PCR testing capacity was exceeded and eligibility rules changed. Due to these inconsistencies in the testing rate, we developed a mechanistic model that was calibrated to serological data (Dec 2021–May 2022) to estimate underreporting and understand the impact of non-pharmaceutical interventions on transmission. Our model considers the epidemiology of SARS-CoV-2 spread, natural and vaccine-derived immunity, and the booster dose vaccination campaign that was ongoing in Newfoundland and Labrador. We found that during the early spread of the Omicron variant, when the eligibility for tests that were reported in the provincial counts was less restrictive, three or fewer infections were unreported per reported case. After March 17, 2022, when test eligibility was more restrictive, the underreporting rate increased steadily, with an average of 24.2 infections unreported infections per reported case. We found that Omicron transmission was lower when schools were closed (mean control reproduction number, ℛ c = 1.98, 95% CI: 1.58–2.37), higher when open (mean ℛ c = 2.71, 95% CI: 2.31–3.11), and of the alert levels, the strictest alert level reduced transmission the most (mean ℛ c = 2.23, 95% CI: 1.98–2.53). When underreporting rates vary, the impact of non-pharmaceutical interventions, such as alert level systems and school closures, cannot be determined from reported cases. Our findings highlight the value of combining serological data with modelling to determine the impact of non-pharmaceutical interventions during pandemics when surveillance systems are constrained.
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (4) , e1013562
Open AccessQuantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada
The highly transmissible Omicron variant of SARS-CoV-2 caused many infections in Newfoundland and Labrador, Canada, and the fraction of infections that were unreported varied as PCR testing capacity was exceeded and eligibility rules changed. Due to these inconsistencies in the testing rate, we developed a mechanistic model that was calibrated to serological data (Dec 2021–May 2022) to estimate underreporting and understand the impact of non-pharmaceutical interventions on transmission. Our model considers the epidemiology of SARS-CoV-2 spread, natural and vaccine-derived immunity, and the booster dose vaccination campaign that was ongoing in Newfoundland and Labrador. We found that during the early spread of the Omicron variant, when the eligibility for tests that were reported in the provincial counts was less restrictive, three or fewer infections were unreported per reported case. After March 17, 2022, when test eligibility was more restrictive, the underreporting rate increased steadily, with an average of 24.2 infections unreported infections per reported case. We found that Omicron transmission was lower when schools were closed (mean control reproduction number, ℛ c = 1.98, 95% CI: 1.58–2.37), higher when open (mean ℛ c = 2.71, 95% CI: 2.31–3.11), and of the alert levels, the strictest alert level reduced transmission the most (mean ℛ c = 2.23, 95% CI: 1.98–2.53). When underreporting rates vary, the impact of non-pharmaceutical interventions, such as alert level systems and school closures, cannot be determined from reported cases. Our findings highlight the value of combining serological data with modelling to determine the impact of non-pharmaceutical interventions during pandemics when surveillance systems are constrained.
- Open Access
Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada
The highly transmissible Omicron variant of SARS-CoV-2 caused many infections in Newfoundland and Labrador, Canada, and the fraction of infections that were unreported varied as PCR testing capacity was exceeded and eligibility rules changed. Due to these inconsistencies in the testing rate, we developed a mechanistic model that was calibrated to serological data (Dec 2021–May 2022) to estimate underreporting and understand the impact of non-pharmaceutical interventions on transmission. Our model considers the epidemiology of SARS-CoV-2 spread, natural and vaccine-derived immunity, and the booster dose vaccination campaign that was ongoing in Newfoundland and Labrador. We found that during the early spread of the Omicron variant, when the eligibility for tests that were reported in the provincial counts was less restrictive, three or fewer infections were unreported per reported case. After March 17, 2022, when test eligibility was more restrictive, the underreporting rate increased steadily, with an average of 24.2 infections unreported infections per reported case. We found that Omicron transmission was lower when schools were closed (mean control reproduction number, ℛ c = 1.98, 95% CI: 1.58–2.37), higher when open (mean ℛ c = 2.71, 95% CI: 2.31–3.11), and of the alert levels, the strictest alert level reduced transmission the most (mean ℛ c = 2.23, 95% CI: 1.98–2.53). When underreporting rates vary, the impact of non-pharmaceutical interventions, such as alert level systems and school closures, cannot be determined from reported cases. Our findings highlight the value of combining serological data with modelling to determine the impact of non-pharmaceutical interventions during pandemics when surveillance systems are constrained. Author summary: Reported COVID-19 cases often underestimate the number of infections, especially when testing capacity is exceeded or eligibility rules change. This occurred in Newfoundland and Labrador, Canada, during the spread of the Omicron variant, when testing rates were uneven and many infections were unreported. Our analysis shows that underreporting increased substantially when eligibility for tests that could be reported in the official counts was restricted to high-risk individuals and people who work with high-risk individuals. Given this eligibility change, the underreporting ratio increased from three or less to an average of 24.2 unreported infections per reported case. We used an epidemiological model to account for the many factors, such as asymptomatic infections and vaccination status, that are known to affect infection spread. We found that transmission was lower when schools were closed, higher when schools were open, and of the alert levels, the strictest alert level reduced spread the most. These results highlight that reported cases alone can produce inaccurate results when testing systems are constrained and the rate of testing is variable. Using our approach of combining serological data with modelling enabled us to evaluate the impact of public health measures. These results support knowledge mobilization to explain to the public why particular public health measures are being implemented during an emergency.
Open AccessQuantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada
The highly transmissible Omicron variant of SARS-CoV-2 caused many infections in Newfoundland and Labrador, Canada, and the fraction of infections that were unreported varied as PCR testing capacity was exceeded and eligibility rules changed. Due to these inconsistencies in the testing rate, we developed a mechanistic model that was calibrated to serological data (Dec 2021–May 2022) to estimate underreporting and understand the impact of non-pharmaceutical interventions on transmission. Our model considers the epidemiology of SARS-CoV-2 spread, natural and vaccine-derived immunity, and the booster dose vaccination campaign that was ongoing in Newfoundland and Labrador. We found that during the early spread of the Omicron variant, when the eligibility for tests that were reported in the provincial counts was less restrictive, three or fewer infections were unreported per reported case. After March 17, 2022, when test eligibility was more restrictive, the underreporting rate increased steadily, with an average of 24.2 infections unreported infections per reported case. We found that Omicron transmission was lower when schools were closed (mean control reproduction number, ℛ c = 1.98, 95% CI: 1.58–2.37), higher when open (mean ℛ c = 2.71, 95% CI: 2.31–3.11), and of the alert levels, the strictest alert level reduced transmission the most (mean ℛ c = 2.23, 95% CI: 1.98–2.53). When underreporting rates vary, the impact of non-pharmaceutical interventions, such as alert level systems and school closures, cannot be determined from reported cases. Our findings highlight the value of combining serological data with modelling to determine the impact of non-pharmaceutical interventions during pandemics when surveillance systems are constrained. Author summary: Reported COVID-19 cases often underestimate the number of infections, especially when testing capacity is exceeded or eligibility rules change. This occurred in Newfoundland and Labrador, Canada, during the spread of the Omicron variant, when testing rates were uneven and many infections were unreported. Our analysis shows that underreporting increased substantially when eligibility for tests that could be reported in the official counts was restricted to high-risk individuals and people who work with high-risk individuals. Given this eligibility change, the underreporting ratio increased from three or less to an average of 24.2 unreported infections per reported case. We used an epidemiological model to account for the many factors, such as asymptomatic infections and vaccination status, that are known to affect infection spread. We found that transmission was lower when schools were closed, higher when schools were open, and of the alert levels, the strictest alert level reduced spread the most. These results highlight that reported cases alone can produce inaccurate results when testing systems are constrained and the rate of testing is variable. Using our approach of combining serological data with modelling enabled us to evaluate the impact of public health measures. These results support knowledge mobilization to explain to the public why particular public health measures are being implemented during an emergency.
- Open Access
- 28 December 2022
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 561, 111378
Pandemic modelling for regions implementing an elimination strategy
- 28 December 2022
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 561, 111378
Open AccessPandemic modelling for regions implementing an elimination strategy